Lilli Gard

432 total citations
18 papers, 206 citations indexed

About

Lilli Gard is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Lilli Gard has authored 18 papers receiving a total of 206 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 6 papers in Epidemiology and 5 papers in Oncology. Recurrent topics in Lilli Gard's work include SARS-CoV-2 and COVID-19 Research (6 papers), SARS-CoV-2 detection and testing (6 papers) and Polyomavirus and related diseases (5 papers). Lilli Gard is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), SARS-CoV-2 detection and testing (6 papers) and Polyomavirus and related diseases (5 papers). Lilli Gard collaborates with scholars based in Netherlands, United States and Germany. Lilli Gard's co-authors include Hubert G.M. Niesters, Coretta van Leer‐Buter, Annelies Riezebos‐Brilman, Kathryn T. Iacono, Jayasri Das Sarma, Susan R. Weiss, Hayley Cassidy, Michael Koval, Lawrence C. Kenyon and Johan W. de Fijter and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Virology.

In The Last Decade

Lilli Gard

15 papers receiving 204 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lilli Gard Netherlands 10 87 67 56 42 28 18 206
Jorge Lévican Chile 8 73 0.8× 69 1.0× 65 1.2× 23 0.5× 16 0.6× 14 192
Lynda Handala France 8 125 1.4× 152 2.3× 19 0.3× 38 0.9× 7 0.3× 12 277
Silvia Linnenweber-Held Germany 8 83 1.0× 176 2.6× 89 1.6× 8 0.2× 35 1.3× 11 333
Paola Pietrosemoli Italy 11 94 1.1× 141 2.1× 159 2.8× 4 0.1× 8 0.3× 30 337
Ramona Liza Tillmann Germany 10 232 2.7× 21 0.3× 268 4.8× 17 0.4× 17 0.6× 15 314
Yiping Chen China 7 71 0.8× 230 3.4× 46 0.8× 5 0.1× 13 0.5× 13 279
Rémy Robinot France 8 181 2.1× 172 2.6× 20 0.4× 24 0.6× 7 0.3× 8 379
Piotr Kardas Switzerland 9 64 0.7× 395 5.9× 46 0.8× 24 0.6× 15 0.5× 16 475
Eugene Major United States 4 60 0.7× 166 2.5× 52 0.9× 3 0.1× 11 0.4× 6 323
Courtney E. Comar United States 6 191 2.2× 13 0.2× 40 0.7× 43 1.0× 7 0.3× 8 280

Countries citing papers authored by Lilli Gard

Since Specialization
Citations

This map shows the geographic impact of Lilli Gard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilli Gard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilli Gard more than expected).

Fields of papers citing papers by Lilli Gard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lilli Gard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilli Gard. The network helps show where Lilli Gard may publish in the future.

Co-authorship network of co-authors of Lilli Gard

This figure shows the co-authorship network connecting the top 25 collaborators of Lilli Gard. A scholar is included among the top collaborators of Lilli Gard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lilli Gard. Lilli Gard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kleine, Ruben H. de, Ellen C. Carbo, Willem S. Lexmond, et al.. (2025). Metagenomic and transcriptomic investigation of pediatric acute liver failure cases reveals a common pathway predominated by monocytes. mBio. 16(4). e0391324–e0391324.
2.
Sabat, Artur J., Lilli Gard, Viktoria Akkerboom, et al.. (2025). Development of a strain-specific PCR as a diagnostic tool for surveillance, detection, and monitoring of vancomycin-resistant Enterococcus faecium during outbreak. Antimicrobial Resistance and Infection Control. 14(1). 23–23. 1 indexed citations
3.
Eijk, Larissa E. van, María F. Vincenti‐González, A.C.M. Veloo, et al.. (2024). Temporal Dynamics and (Para)Clinical Factors Associated With (Long) Viral RNA Shedding in COVID‐19 Nonhospitalized Individuals – The COVID‐HOME Study. Journal of Medical Virology. 96(12). e70125–e70125.
4.
Gard, Lilli, et al.. (2023). Understanding torquetenovirus (TTV) as an immune marker. Frontiers in Medicine. 10. 1168400–1168400. 28 indexed citations
5.
Rondaan, Christien, et al.. (2023). COVID or no COVID: Interpreting inconclusive SARS-CoV-2 qPCR results in different populations and platforms. SHILAP Revista de lepidopterología. 3(2). 100145–100145. 2 indexed citations
6.
Knoester, Marjolein, Lilli Gard, Alewijn Ott, et al.. (2023). Changes in enterovirus epidemiology after easing of lockdown measures. Journal of Clinical Virology. 169. 105617–105617. 15 indexed citations
7.
Gard, Lilli, Greetje A. Kampinga, Marleen van Oosten, et al.. (2023). First evaluation of a commercial multiplex PCR panel for rapid detection of pathogens associated with acute joint infections. Journal of Bone and Joint Infection. 8(1). 45–50. 15 indexed citations
8.
Piek, Arnold, et al.. (2022). SARS-CoV-2 antigen tests for screening of healthcare workers; experience with over 48,000 combined antigen tests and RT-PCR tests. Journal of Clinical Virology. 158. 105326–105326. 4 indexed citations
9.
Cassidy, Hayley, et al.. (2022). Evaluation of the QIAstat-Dx RP2.0 and the BioFire FilmArray RP2.1 for the Rapid Detection of Respiratory Pathogens Including SARS-CoV-2. Frontiers in Microbiology. 13. 854209–854209. 13 indexed citations
10.
Gard, Lilli, Hubert G.M. Niesters, Willem J. van Son, et al.. (2022). Longitudinal monitoring of BKPyV miRNA levels in kidney transplant recipients with BKPyV‐related pathology reflects viral DNA levels and remain high in viremia patients after clearance of viral DNA. Transplant Infectious Disease. 24(6). e13927–e13927. 2 indexed citations
11.
Gard, Lilli, et al.. (2021). Validation and verification of the GeneFinder™ COVID-19 Plus RealAmp kit on the ELITe InGenius® instrument. Journal of Virological Methods. 300. 114378–114378. 4 indexed citations
12.
Boef, Anna G. C., Lilli Gard, Mariëtte Lokate, et al.. (2021). Viral load dynamics in intubated patients with COVID-19 admitted to the intensive care unit. Journal of Critical Care. 64. 219–225.
13.
Cassidy, Hayley, et al.. (2021). A discussion of syndromic molecular testing for clinical care. Journal of Antimicrobial Chemotherapy. 76(Supplement_3). iii58–iii66. 15 indexed citations
14.
Wunderink, Herman F., Caroline S. de Brouwer, Lilli Gard, et al.. (2019). Source and Relevance of the BK Polyomavirus Genotype for Infection After Kidney Transplantation. Open Forum Infectious Diseases. 6(3). ofz078–ofz078. 20 indexed citations
15.
Gard, Lilli, Hubert G.M. Niesters, Willem J. van Son, et al.. (2017). A delicate balance between rejection and BK polyomavirus associated nephropathy; A retrospective cohort study in renal transplant recipients. PLoS ONE. 12(6). e0178801–e0178801. 14 indexed citations
17.
Gard, Lilli, Hubert G.M. Niesters, & Annelies Riezebos‐Brilman. (2015). A real time genotyping PCR assay for polyomavirus BK. Journal of Virological Methods. 221. 51–56. 14 indexed citations
18.
Sarma, Jayasri Das, Kathryn T. Iacono, Lilli Gard, et al.. (2008). Demyelinating and Nondemyelinating Strains of Mouse Hepatitis Virus Differ in Their Neural Cell Tropism. Journal of Virology. 82(11). 5519–5526. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026